News Interim report for the first nine months of 2022 Please read the full announcement in PDF Attachment 2022_27_Q32022_CompanyAnnouncement Continue Reading Previous Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022Next APEIRON Respiratory Therapies announces positive results from Phase I trial of inhaled APN01 Related Stories News Fireflies Expands Beyond Meeting Intelligence and Launches Daily Briefs to Help People Prioritize Work Across Meetings, Email, and Slack News Mitesco Provides Business Update on Ai Software, Edge Computing and Strategic Growth Initiatives News AcuityTec Delivers Smarter Risk Intelligence and Greater Control Across Identity and Transactions News Decusoft Unifies Performance and Compensation Management in Latest Compose Release News Cycode Builds On Shift to AI™ with Agentic Workflows: Agents Now Act the Moment Risk Appears Across the ADLC News Synsira Launches Kind Local Pro with 100% On-Device AI
